Tim Hortons downgraded to 'sell' at Goldman Sachs
Coffee and donut chain Tim Hortons Inc. was downgraded to a ``sell'' by Goldman Sachs on Friday on expectations that there will be few near-term catalysts for the shares.
Goldman Sachs downgrades Healthways Inc. from Neutral to Sell but raises their price target from $9 to $10, which still suggest 31% downside to the current market price.